Prospects for overcoming maturational and genetic barriers to the human antibody response to the capsular polysaccharide of Haemophilus influenzae type b.

Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines. Infect Immun (1995) 0.83

Control of neonatal group B streptococcal infection. J R Soc Med (1993) 0.75

Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med (1994) 2.84

Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30

Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest (2001) 2.26

Characterization of lipopolysaccharide of Haemophilus influenzae. J Infect Dis (1978) 2.18

Protection from infection with Haemophilus influenzae type b by monoclonal antibody to the capsule. J Infect Dis (1982) 1.57

Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis (1998) 1.55

Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults. J Immunol (1985) 1.48

Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. J Immunol (1986) 1.38

Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197. J Immunol (1989) 1.36

Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. Nucleotide sequences of monospecific anti-Haemophilus antibodies and polyspecific antibodies cross-reacting with self antigens. J Clin Invest (1993) 1.27

Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197. J Clin Invest (1985) 1.25

Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens. J Immunol Methods (2001) 1.24

Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations. J Clin Invest (1992) 1.21

Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b. J Pediatr (1985) 1.21

Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants. J Exp Med (1986) 1.17

Immunoglobulin VH gene expression in human B cell lines and tumors: biased VH gene expression in chronic lymphocytic leukemia. Int Immunol (1989) 1.14

Somatic mutation of human immunoglobulin V genes in the X-linked HyperIgM syndrome. J Clin Invest (1995) 1.08

Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis (1984) 1.05

Immunochemical variables affecting radioantigen-binding assays of antibody to Haemophilus influenzae type b capsular polysaccharide in childrens' sera. J Infect Dis (1987) 1.02

The necessity for T cell help for human tonsil B cell responses to pokeweed mitogens: induction of DNA synthesis, immunoglobulin, and specific antibody production with a T cell helper factor produced with pokeweed mitogen. J Immunol (1977) 1.02

Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B. J Immunol (1982) 0.99

A polysaccharide-protein complex from Haemophilus influenzae type b. II. Human antibodies to its somatic components. J Infect Dis (1981) 0.98

Immunospecificity and quantitation of an enzyme-linked immunosorbent assay for group B streptococcal antibody. J Clin Microbiol (1982) 0.98

Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. J Immunol (1997) 0.98

Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine. N Engl J Med (1986) 0.96

Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. J Allergy Clin Immunol (1983) 0.94

Protective human hybridoma antibody to tetanus toxin. J Clin Invest (1982) 0.93

Neonatal passive immunization by maternal vaccination. Obstet Gynecol (1984) 0.92

The IgG1 subclass preference of selected, naturally occurring antipolysaccharide antibodies. Monogr Allergy (1988) 0.92

Isolation of germinal centerlike events from human spleen RNA. Somatic hypermutation of a clonally related VH6DJH rearrangement expressed with IgM, IgG, and IgA. J Clin Invest (1993) 0.92

A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults. J Infect Dis (1981) 0.91

A polysaccharide-protein complex from Haemophilus influenzae type b. I. Activity in weanling rabbits and human T lymphocytes. J Infect Dis (1981) 0.90

A mucosal antibody response following systemic Haemophilus influenzae type B infection in children. J Clin Invest (1981) 0.90

Use of the most JH-proximal human Ig H chain V region gene, VH6, in the expressed immune repertoire. J Immunol (1993) 0.90

Tetracyclines inhibit activated B cell function. Int Immunol (2001) 0.90

Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. Blood (1997) 0.90

Cefamandole failure in ampicillin-resistant Haemophilus influenzae b pneumonia. South Med J (1981) 0.89

Breast milk antibody to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1980) 0.88

Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit. Eur J Immunol (1999) 0.87

Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes. Infect Immun (2001) 0.87

Maternal immunization to prevent neonatal infections. N Engl J Med (1988) 0.86

In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 0.86

Reproducible production of protective human monoclonal antibodies by fusion of peripheral blood lymphocytes with a mouse myeloma cell line. J Infect Dis (1984) 0.83

Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. Blood Cells Mol Dis (2001) 0.82

IgG penetration into the cerebrospinal fluid in a rabbit model of meningitis. J Infect Dis (1987) 0.81

Selective concentration of IgD class-specific antibodies in human milk. Clin Exp Immunol (1990) 0.80

The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants. Infect Immun (1995) 0.80

Morphology, surface markers, and in vitro responses of a human leukemic T cell. Clin Immunol Immunopathol (1975) 0.80

Suppression of tumorigenicity in human ovarian carcinoma cell line SKOV-3 by microcell-mediated transfer of chromosome 11. Cancer Genet Cytogenet (2001) 0.80

Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides. Pediatr Infect Dis J (1988) 0.80

Postimmunization antibody to the Haemophilus influenzae type b capsule in breast milk. J Infect Dis (1985) 0.79

Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro). Cell Immunol (1993) 0.79

Inherent properties of somatic hypermutation as revealed by human non-productive VH6 immunoglobulin rearrangements. Immunology (1998) 0.78

Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers. Contrib Microbiol Immunol (1989) 0.77

Relationship between naturally occurring human mucosal and serum antibody to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1982) 0.77

Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report. Adv Exp Med Biol (1989) 0.75

In vivo production of human hybridoma antibody to the Haemophilus influenzae B capsule in athymic nude mice. J Infect Dis (1984) 0.75

The challenges of vaccinating the very young: lessons from a very old system of host defense. Vaccine (1999) 0.75

Induction of a specific antibody response in human B cells: role of a human antigenic nonspecific T-cell soluble factor and requirement for antigen. Cell Immunol (1977) 0.75

Surface receptors in B lymphocyte activation by antigens. Adv Exp Med Biol (1976) 0.75

Monoclonal antibodies. Clinical relevance to pediatrics. Am J Dis Child (1983) 0.75

Securing the future. Arch Pediatr Adolesc Med (1996) 0.75

Functional characterization of renal infiltrating cells following allograft nephrectomy. Transplant Proc (1987) 0.75

Autologous mixed lymphocyte reaction in human neonatal lymphocytes. Hum Immunol (1989) 0.75

Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide. J Allergy Clin Immunol (1990) 0.75

Oncogene elements within an endogenous retrovirus. Acta Virol (1993) 0.75

Human monoclonal lambda light chain protein exhibits specific binding to the variable region of monoclonal anti-IgE antibody. Cell Immunol (1994) 0.75